The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate

Clin Infect Dis. 2010 Aug 1;51(3):366-7; author reply 367-8. doi: 10.1086/654806.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / adverse effects*
  • Chemical and Drug Induced Liver Injury*
  • Humans
  • Isoniazid / administration & dosage
  • Isoniazid / adverse effects
  • Pyrazinamide / administration & dosage
  • Pyrazinamide / adverse effects
  • Rifampin / administration & dosage
  • Rifampin / adverse effects
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Isoniazid
  • Rifampin